CN102973519A - 阿莫西林颗粒及其制备工艺 - Google Patents
阿莫西林颗粒及其制备工艺 Download PDFInfo
- Publication number
- CN102973519A CN102973519A CN2012105713947A CN201210571394A CN102973519A CN 102973519 A CN102973519 A CN 102973519A CN 2012105713947 A CN2012105713947 A CN 2012105713947A CN 201210571394 A CN201210571394 A CN 201210571394A CN 102973519 A CN102973519 A CN 102973519A
- Authority
- CN
- China
- Prior art keywords
- amoxicillin
- amoxicillin granules
- granules according
- polyvidone
- granules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 60
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title claims abstract description 54
- 229960003022 amoxicillin Drugs 0.000 title claims abstract description 53
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 238000005516 engineering process Methods 0.000 title claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 11
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 11
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 15
- 239000000853 adhesive Substances 0.000 claims description 15
- 230000001070 adhesive effect Effects 0.000 claims description 15
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 15
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 15
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 15
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 15
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 14
- 229930006000 Sucrose Natural products 0.000 claims description 14
- 239000005720 sucrose Substances 0.000 claims description 14
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 13
- 229930195725 Mannitol Natural products 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 239000008101 lactose Substances 0.000 claims description 13
- 239000000594 mannitol Substances 0.000 claims description 13
- 235000010355 mannitol Nutrition 0.000 claims description 13
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 11
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 11
- 229940013618 stevioside Drugs 0.000 claims description 11
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 11
- 235000019202 steviosides Nutrition 0.000 claims description 11
- 244000248349 Citrus limon Species 0.000 claims description 8
- 235000005979 Citrus limon Nutrition 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 7
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 7
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 7
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 7
- 239000007968 orange flavor Substances 0.000 claims description 7
- 229920003081 Povidone K 30 Polymers 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 2
- 239000007779 soft material Substances 0.000 claims description 2
- 238000005469 granulation Methods 0.000 abstract description 10
- 230000003179 granulation Effects 0.000 abstract description 10
- 239000011230 binding agent Substances 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 229940069328 povidone Drugs 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 32
- 238000003756 stirring Methods 0.000 description 18
- 239000012535 impurity Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 229920002307 Dextran Polymers 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229920002521 macromolecule Polymers 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 238000005276 aerator Methods 0.000 description 4
- 235000021050 feed intake Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000005453 pelletization Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- NWYRNCMKWHKPAI-UHFFFAOYSA-N C(=O)=O.[Na] Chemical compound C(=O)=O.[Na] NWYRNCMKWHKPAI-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009775 high-speed stirring Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002270 exclusion chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 201000005354 penicillin allergy Diseases 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 150000003952 β-lactams Chemical group 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210571394.7A CN102973519B (zh) | 2012-12-26 | 2012-12-26 | 阿莫西林颗粒及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210571394.7A CN102973519B (zh) | 2012-12-26 | 2012-12-26 | 阿莫西林颗粒及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102973519A true CN102973519A (zh) | 2013-03-20 |
CN102973519B CN102973519B (zh) | 2014-08-13 |
Family
ID=47848056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210571394.7A Active CN102973519B (zh) | 2012-12-26 | 2012-12-26 | 阿莫西林颗粒及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102973519B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106344522A (zh) * | 2016-11-11 | 2017-01-25 | 河北利华药业有限公司 | 一种兽用阿莫西林颗粒及其制备方法 |
CN106822113A (zh) * | 2015-12-03 | 2017-06-13 | 康普药业股份有限公司 | 一种阿莫西林药物组合物 |
CN107115316A (zh) * | 2017-05-18 | 2017-09-01 | 海口市制药厂有限公司 | 一种稳定的阿莫西林颗粒剂组合物、其制备方法及用途 |
CN108969488A (zh) * | 2018-07-30 | 2018-12-11 | 石药集团中诺药业(石家庄)有限公司 | 一种质量稳定的阿莫西林颗粒 |
CN113069418A (zh) * | 2021-04-21 | 2021-07-06 | 海南通用三洋药业有限公司 | 一种阿莫西林颗粒的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005016311A1 (en) * | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
CN101816635A (zh) * | 2010-05-17 | 2010-09-01 | 广东恒健制药有限公司 | 头孢菌素类混悬颗粒及其制备方法 |
-
2012
- 2012-12-26 CN CN201210571394.7A patent/CN102973519B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005016311A1 (en) * | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
CN101816635A (zh) * | 2010-05-17 | 2010-09-01 | 广东恒健制药有限公司 | 头孢菌素类混悬颗粒及其制备方法 |
Non-Patent Citations (2)
Title |
---|
《河北工业科技》 20110531 张树生 "阿莫西林舒巴坦匹酯分散片处方工艺研究" 第28卷, 第3期 * |
张树生: ""阿莫西林舒巴坦匹酯分散片处方工艺研究"", 《河北工业科技》, vol. 28, no. 3, 31 May 2011 (2011-05-31) * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106822113A (zh) * | 2015-12-03 | 2017-06-13 | 康普药业股份有限公司 | 一种阿莫西林药物组合物 |
CN106344522A (zh) * | 2016-11-11 | 2017-01-25 | 河北利华药业有限公司 | 一种兽用阿莫西林颗粒及其制备方法 |
CN106344522B (zh) * | 2016-11-11 | 2019-04-09 | 河北利华药业有限公司 | 一种兽用阿莫西林颗粒及其制备方法 |
CN107115316A (zh) * | 2017-05-18 | 2017-09-01 | 海口市制药厂有限公司 | 一种稳定的阿莫西林颗粒剂组合物、其制备方法及用途 |
CN108969488A (zh) * | 2018-07-30 | 2018-12-11 | 石药集团中诺药业(石家庄)有限公司 | 一种质量稳定的阿莫西林颗粒 |
CN108969488B (zh) * | 2018-07-30 | 2021-05-25 | 石药集团中诺药业(石家庄)有限公司 | 一种阿莫西林颗粒 |
CN113069418A (zh) * | 2021-04-21 | 2021-07-06 | 海南通用三洋药业有限公司 | 一种阿莫西林颗粒的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102973519B (zh) | 2014-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102973519B (zh) | 阿莫西林颗粒及其制备工艺 | |
CN102106807B (zh) | 一种固体制剂的制备方法及所得固体制剂 | |
CN103845299B (zh) | 一种治疗心血管疾病的缓释片及其制备方法 | |
CN104306344B (zh) | 一种阿齐沙坦片剂及其制备工艺 | |
CN102861106A (zh) | 一种复方氨酚烷胺微丸的制备方法 | |
CN104666262B (zh) | 一种利伐沙班片 | |
CN103417512A (zh) | 一种阿莫西林胶囊剂及其制备方法 | |
CN112791054B (zh) | 一种干混悬剂的干法制粒法 | |
CN103446068A (zh) | 硼替佐米冻干组合物及其制备方法 | |
CN105358137A (zh) | Sovaprevir片剂 | |
CN104367551B (zh) | 一种阿瑞匹坦复合物及其制备方法 | |
CN105055362B (zh) | 一种厄贝沙坦氢***片及其制备方法 | |
CN114288259B (zh) | 一种维生素b2的速释制剂及制备方法 | |
CN103301081B (zh) | 一种头孢地尼分散片及其制备方法 | |
CN102106824B (zh) | 一种右旋佐匹克隆固体制剂及其制备方法 | |
CN104055741A (zh) | 一种孟鲁司特钠片剂及其制备方法 | |
CN106749174A (zh) | 一种西他沙星二水合物晶型、制备方法及其组合物片剂 | |
CN102531936A (zh) | 盐酸赖氨酸三水合物及其制备方法 | |
CN108969488B (zh) | 一种阿莫西林颗粒 | |
CN102058602B (zh) | 一种稳定的含氯沙坦钾和氢***的口服固体制剂 | |
CN106860407A (zh) | 一种利伐沙班片 | |
CN103110590B (zh) | 赛米司酮固体制剂及其制备方法 | |
CN102499909B (zh) | 伊曲康唑分散片及其制备方法 | |
CN106727385A (zh) | 一种新的阿莫西林片 | |
CN106822026A (zh) | 一种新的阿莫西林胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Xiaotao Inventor after: Yang Xiaobing Inventor after: Yang Lu Inventor after: Wu Sumin Inventor after: Song Xiangzhen Inventor after: Xue Xiaobing Inventor after: Zhu Yue Inventor after: Liu Jinghui Inventor after: Cao Fang Inventor after: Li Wei Inventor after: Huang Haiyan Inventor before: Wu Xiaotao Inventor before: Yang Xiaobing Inventor before: Wu Sumin Inventor before: Song Xiangzhen Inventor before: Xue Xiaobing Inventor before: Zhu Yue Inventor before: Liu Jinghui Inventor before: Cao Fang Inventor before: Li Wei Inventor before: Huang Haiyan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WU XIAOTAO WU SUMIN SONG XIANGZHEN XUE XIAOBING ZHU YUE LIU JINGHUI CAO FANG LI WEI HUANG HAIYAN YANG XIAOBING TO: WU XIAOTAO WU SUMIN SONG XIANGZHEN XUE XIAOBING ZHU YUE LIU JINGHUI CAO FANG LI WEI HUANG HAIYAN YANG XIAOBING YANG LU |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: Kexinlu Liuhe District of Nanjing City, Jiangsu Province, No. 63 211500 Patentee after: C & O Pharmaceutical Technology (Holdings) Ltd. Patentee after: Chang'ao Science and Technology of Medical Industry Co., Ltd., Nanjing Address before: 211500 No. eight hundred, No. 2, Liuhe District, Jiangsu, Nanjing Patentee before: C & O Pharmaceutical Technology (Holdings) Ltd. Patentee before: Chang'ao Science and Technology of Medical Industry Co., Ltd., Nanjing |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: No. 63 Kexin Road, Jiangbei New District, Nanjing City, Jiangsu Province, 210000 Co-patentee after: Chang'ao Science and Technology of Medical Industry Co., Ltd., Nanjing Patentee after: C & O Pharmaceutical Technology (Holdings) Ltd. Address before: Kexinlu Liuhe District of Nanjing City, Jiangsu Province, No. 63 211500 Co-patentee before: Chang'ao Science and Technology of Medical Industry Co., Ltd., Nanjing Patentee before: C & O Pharmaceutical Technology (Holdings) Ltd. |